Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal baclofen versus placebo in dystonic cerebral palsy
NL-OMON45097Active, not recruiting
- Sponsor
- Amsterdam UMC
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in dystonic cerebral palsy and dystonia comparing Intrathecal baclofen with Placebo (2 arms). Primary endpoint: Goal Attainment Scaling. Started Jan 2013; status: active, not recruiting.
02
Drugs
baclofen
03
Conditions
dystonic cerebral palsydystonia
Beyond the preview
Go deeper on NL-OMON45097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45097.